Natixis’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $255K | Sell |
|
|||||
|
2025
Q1 | $286K | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $44.4K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $60.8K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $88K | Sell |
|
|||||
|
2021
Q4 | $815K | Sell |
|
|||||
|
2021
Q3 | $1.14M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $1.28M | Buy |
|
|||||
|
2020
Q4 | $987K | Sell |
|
|||||
|
2020
Q3 | $1.04M | Sell |
|
|||||
|
2020
Q2 | $5.07M | Buy |
|
|||||
|
2020
Q1 | $1.94M | Sell |
|
|||||
|
2019
Q4 | $2.58M | Buy |
|
|||||
|
2019
Q3 | $1.75M | Buy |
|
|||||
|
2019
Q2 | $2.17M | Buy |
|
|||||
|
2019
Q1 | $1.06M | Sell |
|
|||||
|
2018
Q4 | $9.06M | Buy |
|
|||||
|
2018
Q3 | $11.6M | Buy |
|
|||||
|
2018
Q2 | $2.02M | Sell |
|
|||||
|
2018
Q1 | $4.31M | Buy |
|
|||||
|
2017
Q4 | $865K | Sell |
|
|||||
|
2017
Q3 | $1.87M | Buy |
|
|||||
|
2017
Q2 | $3.51M | Buy |
|
|||||
|
2017
Q1 | $2.16M | Buy |
|
|||||
|
2016
Q4 | $1.86M | Buy |
|
|||||
|
2016
Q3 | $1.32M | Buy |
|
|||||
|
2016
Q2 | $473K | Buy |
|
|||||
|
2016
Q1 | $278K | Buy |
|
|||||
|
2015
Q4 | $211K | Buy |
|
|||||
|
2015
Q2 | – | Sell |
|
|||||
|
2015
Q1 | $270K | Sell |
|
|||||
|
2014
Q4 | $377K | Hold |
|
|||||
|
2014
Q3 | $352K | Buy |
|
|||||
|
2014
Q2 | $271K | Sell |
|
|||||
|
2014
Q1 | $866K | Sell |
|
|||||
|
2013
Q4 | $2.71M | Hold |
|
|||||
|
2013
Q3 | $2.55M | Buy |
|
|||||
|
2013
Q2 | $2.64M | Buy |
|